Xeroderma pigmentosum and skin cancer

Advances in Experimental Medicine and Biology

Volumn 637, Issue , 2008, Pages 19-27

  Daya Grosjean, Leela ^a,b  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CYTOKINE; GAMMA INTERFERON; PROTEIN P53; REACTIVE OXYGEN METABOLITE; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

BASAL CELL CARCINOMA; BASAL CELL NEVUS SYNDROME; CANCER INHIBITION; CANCER SUSCEPTIBILITY; CELL ACTIVITY; CYTOKINE PRODUCTION; DISEASE EXACERBATION; DNA REPAIR; ENZYME ACTIVATION; EPIDERMODYSPLASIA VERRUCIFORMIS; EXCISION REPAIR; GENE CONTROL; GENE MUTATION; GENETIC ANALYSIS; GENETIC VARIABILITY; HUMAN; HYPERSENSITIVITY; IMMUNE DEFICIENCY; INFECTION RISK; LYMPHOCYTOPOIESIS; MELANOMA; MISSENSE MUTATION; NATURAL KILLER CELL; ONCOGENE; ONCOGENE RAS; ORGAN TRANSPLANTATION; OXIDATIVE STRESS; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SIGNAL TRANSDUCTION; SKIN CANCER; SKIN CARCINOGENESIS; SQUAMOUS CELL CARCINOMA; SUNLIGHT; TUMOR SUPPRESSOR GENE; WART VIRUS; XERODERMA PIGMENTOSUM; GENETICS; MUTATION; PATHOLOGY; RADIATION INJURY; SKIN TUMOR; ULTRAVIOLET RADIATION;

GENES, TUMOR SUPPRESSOR; HUMANS; MUTATION; NEOPLASMS, RADIATION-INDUCED; ONCOGENES; SKIN NEOPLASMS; ULTRAVIOLET RAYS; XERODERMA PIGMENTOSUM;

EID: 60549084361     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-09599-8_3     Document Type: Review

References (52)

1. Friedbcrg EC, Aguilcra A, Gcllert M et al. DNA repair: from molecular mechanism to human disease. DNA Repair (Amst) 2006; 5(8):986-996.
2. Cleaver JE. Cancer in xeroderma pigmentosum and related disorders of DNA repair. Nat Rev Cancer 2005; 5(7):564-573.
3. Lehmann AR. DNA repair-deficient diseases, xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy. Biochimie 2003; 85(11): 1101-1111.
4. van Stceg H, Kraemer KH. Xeroderma pigmentosum and the role of UV-induced DNA damage in skin cancer. Mol Med Today 1999; 5(2):86-94.
5. Kraemer KH, Lee MM, Scotto J. Xeroderma pigmentosum. Cutaneous, ocular and neurologic abnormalities in 830 published cases. Arch Dermatol 1987; 123(2):241-250.
6. Boukamp P. Nonmelanoma skin cancer: what drives tumor development and progression? Carcinogenesis 2005; 26(10):1657-1667.
7. Mclnikova VO, Ananthaswamy HN. Cellular and molecular events leading to the development of skin cancer. Mutat Res 2005; 571(1-2):91-106.
8. Daya-Grosjean L, Sarasin A. The role of UV induced lesions in skin carcinogenesis: an overview of oncogene and tumor suppressor gene modifications in xeroderma pigmentosum skin tumors. Mutat Res 2005; 571(l-2):43-56.
9. Kraemer KH. Nucleotide excision repair genes involved in xeroderma pigmentosum. Jpn J Cancer Res 1994; 85(2):inside front cover.
10. Copeland NE, Hanke CW, Michalak JA. The molecular basis of xeroderma pigmentosum. Dermatol Surg 1997; 23(6):447-455.
11. Hirai Y, Kodama Y, Moriwaki S et al. Heterozygous individuals bearing a founder mutation in the XPA DNA repair gene comprise nearly 1% of the Japanese population. Mutat Res 2006; 601(1-2):17M78.
12. Kraemer KH, Levy DD, Parris CN et al. Xeroderma pigmentosum and related disorders: examining the linkage between defective DNA repair and cancer. J Invest Dermatol 1994; 103(5 Suppl):96S-101S.
13. Oh KS, Khan SG, Jaspers NG et al. Phenotypic heterogeneity in the XPB DNA helicase gene (ERCC3): xeroderma pigmentosum without and with Cockayne syndrome. Hum Mutat 2006; 27(11):1092-1103.
14. Moussaid L, Benchikhi H, Boukind EH et al. Cutaneous tumors during xeroderma pigmentosum in Morocco: study of 120 patients. Ann Dermatol Venereol. 2004; 131(1 Pt l):29-33.
15. Khatri ML, Bemghazil M, Shafi M et al. Xeroderma pigmentosum in Libya. Int J Dermatol 1999; 38(7):520-524.
16. Khatri ML, Shafi M, Mashina A. Xeroderma pigmentostun. A clinical study of 24 Libyan cases. J Am Acad Dermatol 1992; 26(l):75-78.
17. Bouadjar B, Ait-Belkacem F, Daya-Grosjean L et al. Xeroderma pigmentosum. A study in 40 Algerian patients. Ann Dermatol Venereol 1996; 123(5):303-306.
18. Thielmann HW, Popanda O, Edler L et al. Clinical symptoms and DNA repair characteristics of xeroderma pigmentosum patients from Germany. Cancer Res 1991; 51(13):3456-3470.
19. Thielmann WW. Xeroderma pigmentosum patients from Germany (the Mannheim XP collection): clinical and biochemical characteristics. Recent Results Cancer Res 1993; 128:275-297.
20. Moriwaki S, Kraemer KH. Xeroderma pigmentosumbridging a gap between clinic and laboratory. Photodermatol Photoimmunol Photomed 2001; 17(2):47-54.
21. Kennedy C, Bajdik CD, Willcmze R et al. The influence of painful sunburns and lifetime sun exposure on the risk of actinic keratoses, seborrheic warts, melanocytic nevi, atypical nevi and skin cancer. J Invest Dermatol 2003; 120(6):1087-1093.
22. Takcbe H, Nishigori C, Tatsumi K. Melanoma and other skin cancers in xeroderma pigmentosum patients and mutation in their cells. J Invest Dermatol 1989; 92(5 Suppl):236S-238S.
23. Kraemer KH, Lee MM, Andrews AD et al. The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. The xeroderma pigmentosum paradigm. Arch Dermatol 1994; 130(8):1018-1021.
24. Pfeifer GP, You YH, Besaratinia A. Mutations induced by ultraviolet light. Mutat Res 2005; 571(1-2):19-31.
25. Halliday GM. Inflammation, gene mutation and photoimmunosuppression in response to UVR-induced oxidative damage contributes to photocarcinogenesis. Mutat Res 2005; 571 (1-2): 107-120.
26. Cadet J, Sage E, Douki T. Ultraviolet radiation-mediated damage to cellular DNA. Mutat Res 2005; 571(l-2):3-17.
27. Vuillaumc M, Daya-Grosjean L, Vincens P et al. Striking differences in cellular catalase activity between two DNA repair-deficient diseases: xeroderma pigmentosum and trichothiodystrophy. Carcinogenesis 1992; 13(3):321-328.
28. Arbault S, Sojic N, Bruce D et al. Oxidative stress in cancer prone xeroderma pigmentosum fibroblasts. Real-time and single cell monitoring of superoxide and nitric oxide production with microelectrodes. Carcinogenesis 2004; 25(4):509-515.
29. Daya-Grosjean L, Dumaz N, Sarasin A. The specificity of p53 mutation spectra in sunlight induced human cancers. J Photochem Photobiol B 1995; 28(2):115-124.
30. Ehrhart JC, Gosselct FP, Culerrier RM et al. UVB-induced mutations in human key gatekeeper genes governing signalling pathways and consequences for skin tumourigenesis. Photochem Photobiol Sci 2003; 2(8):825-834.
31. Ohvier M, Hussain SP, Caron de Fromentel C et al. TP53 mutation spectra and load: a tool for generating hypotheses on the etiology of cancer. lARC Sci Publ 2004; (157):247-270.
32. Giglia-Mari G, Sarasin A. TP53 mutations in human skin cancers. Hum Mutat 2003; 21 (3) :217-228.
33. Spatz A, Giglia-Mari G, Benhamou S et al. Association between DNA repair-deficiency and high level of p53 mutations in melanoma ofXeroderma pigmentosum. Cancer Res 2001; 61(6):2480-2486.
34. D'Errico M, Calcagnile A, Canzona F et al. UV mutation signature in tumor suppressor genes involved in skin carcinogenesis in xeroderma pigmentosum patients. Oncogene 2000; 19(3):463-467.
35. Liggett WH, Jr., Sidransky D. Role of the pl6 tumor suppressor gene in cancer. J Clin Oncol 1998; 16(3):1197-1206.
36. Soufir N, Moles JP, Vilmer C et al. P16 UV mutations in human skin epithelial tumors. Oncogene 1999; 18(39):5477-5481.
37. Soufir N, Ribojad M, Magnaldo T et al. Germline and somatic mutations of the INK4a-ARF gene in a xeroderma pigmentosum group C patient. J Invest Dermatol 2002; 119(6): 1355-1360.
38. Brown VL, Harwood CA, Crook T et al. pl6INK4a and pl4ARF tumor suppressor genes are commonly inactivated in cutaneous squamous cell carcinoma. J Invest Dermatol 2004; 122(5): 1284-1292.
39. Soufir N, Daya-Grosjean L, de La Salmoniere P et al. Association between INK4a-ARF and p53 mutations in skin carcinomas of xeroderma pigmentosum patients. J Natl Cancer Inst 2000; 92(22): 1841-1847.
40. Lynch HT, Shaw TG, Lynch JF. Inherited predisposition to cancer: a historical overview. Am J Med Genet C Semin Med Genet 2004; 129(l):5-22.
41. Daya-Grosjean L, Robert C, Drougard C et al. High mutation frequency in ras genes of skin tumors isolated from DNA repair deficient xeroderma pigmentosum patients. Cancer Res 1993; 53(7):1625-1629.
42. Couve-Privat S, Bouadjar B, Avril MF et al. Significantly high levels of ultraviolet-specific mutations in the smoothened gene in basal cell carcinomas from DNA repair-deficient xeroderma pigmentosum patients. Cancer Res 2002; 62(24) :7186-7189.
43. Couve-Privat S, Le Bret M, Traiffort E et al. Functional analysis of novel sonic hedgehog gene mutations identified in basal cell carcinomas fi-om xeroderma pigmentosum patients. Cancer Res 2004; 64(10):3559-3565.
44. Keijzer W, Mulder MP, Langeveld JC et al. Establishment and characterization of a melanoma cell line firom a xeroderma pigmentosum patient: activation of N-ras at a potential pyrimidine dimer site. Cancer Res 1989; 49(5):1229-1235.
45. Daya-Grosjean L, Couve-Privat S. Sonic hedgehog signaling in basal cell carcinomas. Cancer Lett 2005; 225(2):181-192.
46. Bodak N, Qucille S, Avril MF et al. High levels of patched gene mutations in basal-cell carcinomas from patients with xeroderma pigmentosum. Proc Natl Acad Sci USA 1999; 96(9):5117-5122.
47. Nishigori C, Yarosh DB, Donawho C et al. The immune system in ultraviolet carcinogenesis. J Investig Dermatol Symp Proc 1996; 1(2):143-146.
48. Gaspari AA, Fleishcr TA, Kraemer KH. Impaired interferon production and natural killer cell activation in patients with the skin cancer-prone disorder, xeroderma pigmentosum. J Clin Invest 1993; 92(3):1135-1142.
49. Suzuki H, Kalair W, Shivji GM et al. Impaired ultraviolet-B-induced cytokine induction in xeroderma pigmentosum fibroblasts. J Invest Dermatol 2001; 117(5):1151-1155.
50. Majewski S, Jablonska S. Epidermodysplasia verruciformis as a model of human papillomavirus-induced genetic cancer of the skin. Arch Dermatol 1995; 131(11):1312-1318.
51. Bordea C, Wojnarowska F, Millard PR et al. Skin cancers in renal-transplant recipients occur more frequently than previously recognized in a temperate climate. Transplantation 2004; 77(4):574-579.
52. Luron L, Avril MF, Sarasin A et al. Prevalence of human papillomavirus in skin tumors from repair deficient xeroderma pigmentosum patients. Cancer Lett 2006.